Soluble biomarkers can provide insight into drug safety and efficacy. Our wide variety of technology platforms allows us to choose the right solution for your biomarker. We have extensive experience in applying these technologies in various matrices such as serum, plasma, BAL, saliva, sputum and tissues. Celerion offers three-tier biomarker validations based on a fit-for-purpose approach in a GLP environment that is consistent with all global regulatory guidelines.
Understanding the context of use (COU) of each assay is critical for bioanalysis. Our scientific experts start biomarker projects with a collaborative discussion to ensure that we build the right assay and generate the appropriate data for your informed decision making. Our strategy for validation optimizes biomarker development costs, speed, and data delivery while ensuring applicable regulatory expectations are met.
We have extensive experience with methods in various matrices including serum, plasma, BAL, saliva, sputum, and tissues. This combined with our wide variety of technology platforms allows us to choose the right solution for your biomarker. Commonly requested analytes include:
Celerion 2026. All Rights Reserved. Privacy & Legal
View Article
Download PDF